CAS: 167354-41-8 - Zosuquidar
Formula:C32H31F2N3O2
InChI:InChI=1S/C32H31F2N3O2/c33-32(34)29-22-7-1-3-9-24(22)31(25-10-4-2-8-23(25)30(29)32)37-17-15-36(16-18-37)19-21(38)20-39-28-13-5-12-27-26(28)11-6-14-35-27/h1-14,21,29-31,38H,15-20H2/t21-,29-,30+,31-/m1/s1
InChI key:InChIKey=IHOVFYSQUDPMCN-DBEBIPAYSA-N
SMILES:FC1(F)C2C=3C=CC=CC3C(C=4C=CC=CC4C21)N5CCN(CC5)CC(O)COC6=CC=CC7=NC=CC=C76
- Synonyms:
- (2R)-1-{4-[(1aR,10bS)-1,1-difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c][7]annulen-6-yl]piperazin-1-yl}-3-(quinolin-5-yloxy)propan-2-ol trihydrochloride
- (2R)-1-{4-[(1aR,6r,10bS)-1,1-Difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c]cyclohepten-6-yl]piperazin-1-yl}-3-(quinolin-5-yloxy)propan-2-ol
- (αR)-4-[(1Aα,6α,10bα)-1,1-difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c]cyclohepten-6-yl]-α-[(5-quinolinyloxy)methyl]-1-piperazineethanol
- 1-Piperazineethanol, 4-[(1aα,6α,10bα)-1,1-difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c]cyclohepten-6-yl]-α-[(5-quinolinyloxy)methyl]-, (αR)-
- Lsn 335979
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
(2R)-1-{4-[(1aR,6r,10bS)-1,1-Difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c]cyclohepten-6-yl]piperazin-1-yl}-3-(quinolin-5-yloxy)propan-2-ol REF: IN-DA00ABM5CAS: 167354-41-8 | 98% | 118.00 €~532.00 € | Fri 03 Jan 25 | |
Zosuquidar REF: TM-T6018LCAS: 167354-41-8 | - - - | 1,184.00 €~2,238.00 € | Fri 10 Jan 25 | |
Zosuquidar REF: 3D-FZ104159CAS: 167354-41-8 | Min. 95% | - - - | Discontinued product |
(2R)-1-{4-[(1aR,6r,10bS)-1,1-Difluoro-1,1a,6,10b-tetrahydrodibenzo[a,e]cyclopropa[c]cyclohepten-6-yl]piperazin-1-yl}-3-(quinolin-5-yloxy)propan-2-ol
Ref: IN-DA00ABM5
1mg | 118.00 € | ||
5mg | 532.00 € |
Zosuquidar
Ref: TM-T6018L
25mg | 1,184.00 € | ||
50mg | 1,749.00 € | ||
100mg | 2,238.00 € |
Zosuquidar
Ref: 3D-FZ104159
1mg | Discontinued | Request information | |
2mg | Discontinued | Request information | |
5mg | Discontinued | Request information | |
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information |